Cargando…
Central Nervous System Demyelination Related to Tumour Necrosis Factor Alpha Inhibitor
BACKGROUND: An association between tumour necrosis factor alpha (TNF-α) inhibitors exposure and central nervous system (CNS) demyelinating disorders has been postulated but is poorly understood. OBJECTIVES: Describe the clinical spectrum and progress of a cohort of patients who developed demyelinati...
Autores principales: | Chey, Shin Yee, Kermode, Allan G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743963/ https://www.ncbi.nlm.nih.gov/pubmed/35024163 http://dx.doi.org/10.1177/20552173211070750 |
Ejemplares similares
-
Cutaneous presentation of cryptococcal infection with subclinical central nervous system involvement secondary to fingolimod therapy
por: Chey, Shin Yee, et al.
Publicado: (2023) -
Tumor necrosis factor alpha inhibitors and demyelinating disease: what is behind it?
por: Kucharz, Eugeniusz Józef, et al.
Publicado: (2021) -
Central nervous system effects of tumor necrosis factor alpha blockade
por: Schett, Georg
Publicado: (2011) -
Demyelinating Disorders of the Central Nervous System
por: Pirko, Istvan, et al.
Publicado: (2007) -
HCV-Related Central and Peripheral Nervous System Demyelinating Disorders
por: Mariotto, Sara, et al.
Publicado: (2014)